Subscribe
Logo small
Search
banner

National Drug Manufacturers postulate in Brussels that Poland should be on the EU's critical drug production map

MedExpress Team

medexpress.pl

Published April 25, 2024 10:50

National Drug Manufacturers postulate in Brussels that Poland should be on the EU's critical drug production map - Header image
Fot. Thinkstock / Getty Images
The National Drug Manufacturers attended the first meeting of the EU Critical Medicines Alliance (April 25), which is designed to assist the European Commission in preventing drug shortages. The basis of its activities is the EU list of critical medicines.

The European Medicines Agency (EMA) published the first version of the EU's list of critical medicines last December 12. It identified products for which continuity of supply is required, and where interruption of treatment could result in serious health damage. Two criteria were taken into account: the severity of the disease and the availability of alternative medicines.

More than 90% of the EU's list of critical medicines are essential off-patent drugs that can be manufactured in our country.

- In Poland we have factories, competence and huge development potential. We are a large country with a strategic location. We can become a produ...

Content locked

To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].

If you already have an account, please log in

Read also